Effects of an EP2 and EP3 Receptor Dual Agonist, ONO‐8055, on a Radical Hysterectomy‐Induced Underactive Bladder Model in Monkeys

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Lower urinary tract symptoms

• Publication date

  2018-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/luts.12166PMID 28439968
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Promising Effects of a Novel EP2 and EP3 Receptor Dual Agonist, ONO-8055, on Neurogenic Underactive Bladder in a Rat Lumbar Canal Stenosis Model.

  2016cited by this paper
• A novel animal model of underactive bladder: Analysis of lower urinary tract function in a rat lumbar canal stenosis model

  2012cited by this paper
• Detrusor underactivity: A plea for new approaches to a common bladder dysfunction

  2011cited by this paper
• Long-term lower urinary tract dysfunction after radical hysterectomy in patients with early postoperative voiding dysfunction

  2010cited by this paper
• Bethanechol Chloride for the Prevention of Bladder Dysfunction After Radical Hysterectomy in Gynecologic Cancer Patients: A Randomized Controlled Trial Study

  2010cited by this paper
• Detrusor underactivity/underactive bladder: new research initiatives needed.

  2010cited by this paper
• Diabetic bladder dysfunction: current translational knowledge.

  2009cited by this paper
• Long-term lower urinary tract dysfunction after radical hysterectomy in patients with early postoperative voiding dysfunction

  2009cited by this paper
• Change in acetylcholine release from rat bladder with partial outlet obstruction

  2008cited by this paper
• Case for pharmacotherapy development for underactive bladder.

  2008cited by this paper
• Restoration of bladder contraction by bone marrow transplantation in rats with underactive bladder.

  2007cited by this paper
• Is the use of parasympathomimetics for treating an underactive urinary bladder evidence‐based?

  2007cited by this paper
• The effects of bethanechol and cisapride on urodynamic parameters in patients undergoing radical hysterectomy for cervical cancer. A randomized, double-blind, placebo-controlled study

  2006cited by this paper
• Differential effects of TAK-802, a selective acetylcholinesterase inhibitor, and carbamate acetylcholinesterase inhibitors on contraction of the detrusor smooth muscle of the guinea pig.

  2005cited by this paper
• Effects of TAK-802, a novel acetylcholinesterase inhibitor, and various cholinomimetics on the urodynamic characteristics in anesthetized guinea pigs.

  2004cited by this paper
• Lower urinary tract function after postoperative radiotherapy in the treatment of cervical cancer.

  2003cited by this paper
• The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society.

  2003cited by this paper
• The standardisation of terminology of lower urinary tract function: Report from the standardisation sub‐committee of the International Continence Society

  2002cited by this paper
• Urinary tract dysfunction after radical hysterectomy for cervical cancer.

  2002cited by this paper
• Lower Urinary Tract Dysfunction as Persistent Complication of Radical Hysterectomy

  1997cited by this paper
• Alterations in the urinary tract after spinal cord injury—diagnosis, prevention and therapy of late sequelae

  1990cited by this paper
• Bladder and urethral function and supersensitivity to subcutaneously administered bethanechol in cats with chronic cauda equina lesions.

  1985cited by this paper

• Leveraging animal models to understand non-motor symptoms of Parkinson's disease.

  2025cites this paper
• Underactive Bladder and Detrusor Underactivity: New Advances and Prospectives

  2023cites this paper
• PGE2 receptors in detrusor muscle: Drugging the undruggable for urgency.

  2020cites this paper
• EP2 and EP3 receptors as therapeutic targets for underactive bladder/detrusor underactivity due to diabetic cystopathy in a type 1 diabetic rat model

  2020cites this paper
• Further characterization of a novel EP2 and EP3 receptor dual agonist, ONO‐8055, on lower urinary tract function in normal and lumbar canal stenosis rats

  2020cites this paper
• Treatment of Voiding LUTS

  2019cites this paper
• Effects of Distigmine on the Mechanical Activity of Urinary Bladder Smooth Muscle.

  2019cites this paper
• Which molecular targets do we need to focus on to improve lower urinary tract dysfunction? ICI‐RS 2017

  2018cites this paper
• Synthesis and evaluation of a potent, well-balanced EP2/EP3 dual agonist.

  2018cites this paper
• New therapeutic directions to treat underactive bladder

  2017cites this paper